Erratum: Short-Term Outcomes for Veterans Receiving Basal Insulin, Metformin, and a Sulfonylurea Who Are Started on a Third Noninsulin Agent Versus Prandial Insulin. Diabetes Spectrum 2018;31:261–266 (doi.org/10.2337/ds17-0068)

Detalles Bibliográficos
Autores principales: Santeusanio, Andrew D., Bowen, Monica M.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: American Diabetes Association 2018
Materias:
Departments
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6243227/
https://www.ncbi.nlm.nih.gov/pubmed/30510394
http://dx.doi.org/10.2337/ds18-er04
_version_ 1783371942627115008
author Santeusanio, Andrew D.
Bowen, Monica M.
author_facet Santeusanio, Andrew D.
Bowen, Monica M.
author_sort Santeusanio, Andrew D.
collection PubMed
description
format Online
Article
Text
id pubmed-6243227
institution National Center for Biotechnology Information
language English
publishDate 2018
publisher American Diabetes Association
record_format MEDLINE/PubMed
spelling pubmed-62432272018-12-03 Erratum: Short-Term Outcomes for Veterans Receiving Basal Insulin, Metformin, and a Sulfonylurea Who Are Started on a Third Noninsulin Agent Versus Prandial Insulin. Diabetes Spectrum 2018;31:261–266 (doi.org/10.2337/ds17-0068) Santeusanio, Andrew D. Bowen, Monica M. Diabetes Spectr Departments American Diabetes Association 2018-11 /pmc/articles/PMC6243227/ /pubmed/30510394 http://dx.doi.org/10.2337/ds18-er04 Text en © 2018 by the American Diabetes Association. Readers may use this article as long as the work is properly cited, the use is educational and not for profit, and the work is not altered. See http://creativecommons.org/licenses/by-nc-nd/3.0 for details.
spellingShingle Departments
Santeusanio, Andrew D.
Bowen, Monica M.
Erratum: Short-Term Outcomes for Veterans Receiving Basal Insulin, Metformin, and a Sulfonylurea Who Are Started on a Third Noninsulin Agent Versus Prandial Insulin. Diabetes Spectrum 2018;31:261–266 (doi.org/10.2337/ds17-0068)
title Erratum: Short-Term Outcomes for Veterans Receiving Basal Insulin, Metformin, and a Sulfonylurea Who Are Started on a Third Noninsulin Agent Versus Prandial Insulin. Diabetes Spectrum 2018;31:261–266 (doi.org/10.2337/ds17-0068)
title_full Erratum: Short-Term Outcomes for Veterans Receiving Basal Insulin, Metformin, and a Sulfonylurea Who Are Started on a Third Noninsulin Agent Versus Prandial Insulin. Diabetes Spectrum 2018;31:261–266 (doi.org/10.2337/ds17-0068)
title_fullStr Erratum: Short-Term Outcomes for Veterans Receiving Basal Insulin, Metformin, and a Sulfonylurea Who Are Started on a Third Noninsulin Agent Versus Prandial Insulin. Diabetes Spectrum 2018;31:261–266 (doi.org/10.2337/ds17-0068)
title_full_unstemmed Erratum: Short-Term Outcomes for Veterans Receiving Basal Insulin, Metformin, and a Sulfonylurea Who Are Started on a Third Noninsulin Agent Versus Prandial Insulin. Diabetes Spectrum 2018;31:261–266 (doi.org/10.2337/ds17-0068)
title_short Erratum: Short-Term Outcomes for Veterans Receiving Basal Insulin, Metformin, and a Sulfonylurea Who Are Started on a Third Noninsulin Agent Versus Prandial Insulin. Diabetes Spectrum 2018;31:261–266 (doi.org/10.2337/ds17-0068)
title_sort erratum: short-term outcomes for veterans receiving basal insulin, metformin, and a sulfonylurea who are started on a third noninsulin agent versus prandial insulin. diabetes spectrum 2018;31:261–266 (doi.org/10.2337/ds17-0068)
topic Departments
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6243227/
https://www.ncbi.nlm.nih.gov/pubmed/30510394
http://dx.doi.org/10.2337/ds18-er04
work_keys_str_mv AT santeusanioandrewd erratumshorttermoutcomesforveteransreceivingbasalinsulinmetforminandasulfonylureawhoarestartedonathirdnoninsulinagentversusprandialinsulindiabetesspectrum201831261266doiorg102337ds170068
AT bowenmonicam erratumshorttermoutcomesforveteransreceivingbasalinsulinmetforminandasulfonylureawhoarestartedonathirdnoninsulinagentversusprandialinsulindiabetesspectrum201831261266doiorg102337ds170068

Ejemplares similares